International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70 | -127 | -256 | -209 | -220 |
| Depreciation Amortization | 165 | 109 | 55 | 206 | 152 |
| Accounts receivable | 43 | -43 | 207 | -484 | -106 |
| Accounts payable and accrued liabilities | 79 | 211 | 271 | -178 | -43 |
| Other Working Capital | -711 | -496 | 224 | -809 | -491 |
| Other Operating Activity | 470 | 273 | -274 | 1,487 | 795 |
| Operating Cash Flow | $-24 | $-73 | $227 | $13 | $87 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -37 | -5 | -166 | -165 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -5 | -3 |
| Other Investing Activity | 0 | 0 | 0 | -5 | -3 |
| Investing Cash Flow | $-40 | $-37 | $-5 | $-171 | $-168 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -200 | -200 | N/A | -200 | -200 |
| Other Financing Activity | 0 | 0 | -5 | 0 | 0 |
| Financing Cash Flow | $-200 | $-200 | $-5 | $-200 | $-200 |
| Beginning Cash Position | 1,230 | 1,230 | 1,230 | 1,588 | 1,588 |
| End Cash Position | 966 | 920 | 1,452 | 1,230 | 1,307 |
| Net Cash Flow | $-264 | $-310 | $222 | $-358 | $-281 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24 | -73 | 227 | 13 | 87 |
| Capital Expenditure | -40 | -37 | -5 | -166 | -165 |
| Free Cash Flow | -64 | -110 | 222 | -153 | -78 |